Beals-Hecht syndrome and choroidal neovascularization

Roberto Gallego-Pinazo, Ruth López-Lizcano, José María Millán, J. Fernando Arevalo, J. Luis Mullor, Manuel Díaz-Llopis

Research output: Contribution to journalArticlepeer-review

Abstract

Purpose: To describe a case of choroidal neovascularization (CNV) in a female diagnosed with Beals-Hecht syndrome. Methods: A retrospective, interventional case is described in a 26-year-old female complaining of metamorphopsia and visual loss in her left eye (counting fingers). The fluorescein angiogram and the optical coherence tomography supported the diagnosis of CNV. Intravitreal ranibizumab was administered. Results: After the third intravitreal ranibizumab, her visual acuity improved to 0.8 and the morphology of the macular area was restored. Conclusions: To our knowledge this is the first report of CNV in Beals-Hecht syndrome treated with ranibizumab. Self-monitoring by periodically performing Amsler grid test is strongly recommended in these patients in order to achieve an early diagnosis of eventual CNV and avoid visual acuity loss.

Original languageEnglish (US)
Pages (from-to)845-847
Number of pages3
JournalClinical Ophthalmology
Volume4
Issue number1
StatePublished - Sep 3 2010
Externally publishedYes

Keywords

  • Beals-Hecht syndrome
  • Choroidal neovascularization
  • Connective tissue disease
  • Ranibizumab

ASJC Scopus subject areas

  • Ophthalmology

Fingerprint

Dive into the research topics of 'Beals-Hecht syndrome and choroidal neovascularization'. Together they form a unique fingerprint.

Cite this